Is Sotera Health Company a good investment? Sotera Health Company (SHC) is currently trading at 16.61 USD. Market analysts have a consensus price target of 21.44 USD. This suggests a potential upside from current levels.
In terms of valuation, the stock trades at a P/E ratio of 27.17. This valuation is generally in line with the broader market.
Earnings Schedule: Sotera Health Company is expected to release its next earnings report on Feb. 23, 2027. The market consensus estimate for Forward EPS is 1.07.
No, it does not currently pay a dividend.
Sotera Health Company is classified as a Stock. You can compare it against its peer in the "Related Symbols" list.
The next earnings date is projected to be Feb. 23, 2027. The company currently has a trailing EPS of 0.60.
Sotera Health Company provides sterilization solutions, lab testing, and advisory services for the healthcare industry in the United States, Canada, Europe, and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. The Sterigenics segment offers outsourced terminal sterilization and irradiation services using gamma irradiation, ethylene oxide processing, and electron beam irradiation technologies for medical devices, pharmaceutical, and food safety and advanced applications markets. The Nordion segment provides Cobalt-60 used in the sterilization and irradiation processes for the medical device, pharmaceutical, food safety, and high-performance materials industries, as well as in the treatment of cancer. It also offers gamma irradiation systems. The Nelson Labs segment provides outsourced microbiological and analytical chemistry testing and advisory services for the medical device and pharmaceutical industries. The company was formerly known as Sotera Health Topco, Inc. and changed its name to Sotera Health Company in October 2020. Sotera Health Company was incorporated in 2015 and is headquartered in Broadview Heights, Ohio.
Community Discussion